Home/Filings/4/0001069530-22-000039
4//SEC Filing

Kupiec James William 4

Accession 0001069530-22-000039

CIK 0001069530other

Filed

Aug 23, 8:00 PM ET

Accepted

Aug 24, 4:02 PM ET

Size

5.1 KB

Accession

0001069530-22-000039

Insider Transaction Report

Form 4
Period: 2022-08-23
Kupiec James William
Chief Clinical Dev. Officer
Transactions
  • Purchase

    Common Stock

    2022-08-23$24.44/sh+2,500$61,1002,500 total
Footnotes (1)
  • [F1]The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $24.41 to $24.44 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote.

Issuer

CASSAVA SCIENCES INC

CIK 0001069530

Entity typeother

Related Parties

1
  • filerCIK 0001839551

Filing Metadata

Form type
4
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 4:02 PM ET
Size
5.1 KB